The Recall Desk
HighFDA (Devices)·Z-2040-2016·Announced 2016-06-29

Immuno-Mycologics Recalls Histoplasma Yeast Complement Fixation Antigen Due to Bacterial Contamination

Immuno-Mycologics, Inc. is recalling 467 units of Histoplasma Yeast Complement Fixation Antigen Dilute (Lot 111WH3) due to bacterial contamination. The product was distributed nationwide to specific states.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves bacterial contamination of a medical diagnostic device. While no specific injuries or illnesses are reported in the source text, the risk of harm from using a contaminated diagnostic tool places this in the High severity category per the rubric for risk-of-harm products where injury has not yet been reported.

Plain-English summary

Immuno-Mycologics, Inc. is recalling 467 units of Histoplasma Yeast Complement Fixation Antigen Dilute, Reference # H30150, Lot 111WH3. The recall was initiated because the device was found to have bacterial contamination.

The product is used to detect antibodies in patient serum by the complement fixation procedure to aid in the diagnosis of four specific fungal diseases: Histoplasmosis, blastomycosis, coccidioidomycosis, and aspergillosis. The affected units were distributed nationwide to Utah, Massachusetts, Ohio, Indiana, North Carolina, New York, Virginia, California, Iowa, and Kentucky.

Healthcare facilities and laboratories should stop using the affected product and contact the recalling firm for instructions on return or disposal. Patients who have already received test results using this product should consult their healthcare provider if they have concerns regarding the accuracy of their diagnosis.

The recalled product

Product
Histoplasma Yeast Complement Fixation Antigen Dilute Ref# H30150 The fungal antigens and positive controls are used to detect antibodies in patient serum by the complement fixation (CF) procedure to aid in the diagnosis of four specific fungal diseases: Histoplasmosis, blastomyc
Affected units
467

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot 111WH3

Distribution

Distributed nationwide across the United States.

The notice also names 10 states specifically: